Stay updated on Nivolumab Combo in MGMT-Silenced mCRC Clinical Trial
Sign up to get notified when there's something new on the Nivolumab Combo in MGMT-Silenced mCRC Clinical Trial page.

Latest updates to the Nivolumab Combo in MGMT-Silenced mCRC Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

- Check32 days agoChange Detected- Revision label updated from v3.4.2 to v3.4.3 in the page footer.SummaryDifference0.0%

- Check60 days agoChange DetectedRevision: v3.4.2 was added. The previous funding-lapse notice and Revision: v3.4.1 were removed.SummaryDifference0.4%

- Check67 days agoChange DetectedA site-wide notice about a lapse in government funding and the NIH Clinical Center’s status was added, and a new revision tag (v3.4.1) was introduced, replacing the previous v3.4.0 tag.SummaryDifference0.4%

- Check74 days agoChange DetectedAdded a glossary toggle (Show glossary) and updated several metadata labels, including revision to v3.4.0 and capitalization changes (e.g., Last Update Submitted that Met QC Criteria, No FEAR Act data).SummaryDifference0.2%

- Check88 days agoChange DetectedAdded Revision: v3.3.4 and removed Revision: v3.3.3 from the page. This is a minor site update with no impact on the study information.SummaryDifference0.0%

Stay in the know with updates to Nivolumab Combo in MGMT-Silenced mCRC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab Combo in MGMT-Silenced mCRC Clinical Trial page.